Product Information
COLESEVELAM 625 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.2705 per EA under NDC 67877050651. Its NADAC has been published 391 times since Jan 2, 2019.
Strength
625 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877050651
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209038On Market Since
10/6/2018
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM 625 MG TABLET has been published 391 times since Jan 2, 2019, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2705 per EA |
|---|---|
| All-time high | $1.8868 (Jan 16, 2019) |
| All-time low | $0.1763 (Jul 17, 2024) |
| 52-week high | $0.3117 |
| 52-week low | $0.2660 |
| Median price | $0.4032 |
| Average price | $0.4977 |
| Largest weekly change | +56.2% (May 17, 2023) |
| Weeks tracked | 391 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Colesevelam HCL market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of COLESEVELAM 625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM 625 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.2705 per EA (NDC 67877050651), effective Jun 24, 2026.
How has the price of COLESEVELAM 625 MG TABLET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM 625 MG TABLET has declined 85.7%. It has been tracked across 391 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for COLESEVELAM 625 MG TABLET?
Since Jan 2, 2019, the NADAC for COLESEVELAM 625 MG TABLET has ranged from a low of $0.1763 (Jul 17, 2024) to a high of $1.8868 (Jan 16, 2019), with a median of $0.4032 per EA.
Are there cheaper alternatives to COLESEVELAM 625 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of COLESEVELAM 625 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures COLESEVELAM 625 MG TABLET?
COLESEVELAM 625 MG TABLET (NDC 67877050651) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification